MISSIONPHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 26902398
Vassingerødvej 9, 3540 Lynge
info@missionpharma.com
tel: 48163248
Income statement (kDKK)
2022 | 2023 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | 942 492.00 | 940 120.00 |
Costs of manufacturing | - 592 483.00 | - 560 025.00 |
External services | - 135 079.00 | - 176 509.00 |
Gross profit | 214 930.00 | 203 586.00 |
Employee benefit expenses | -56 410.00 | -56 972.00 |
Other operating expenses | - 746.00 | -1 376.00 |
Total depreciation | -1 550.00 | -1 415.00 |
EBIT | 156 224.00 | 143 823.00 |
Other financial income | 1 977.00 | 5 591.00 |
Other financial expenses | -6 124.00 | -2 765.00 |
Net income from associates (fin.) | 1 718.00 | 5 521.00 |
Pre-tax profit | 153 795.00 | 152 170.00 |
Income taxes | -33 785.00 | -32 305.00 |
Net earnings | 120 010.00 | 119 865.00 |
Assets (kDKK)
2022 | 2023 | |
---|---|---|
Development expenditure | 1 295.00 | |
Intangible assets total | 1 295.00 | |
Land and waters | 21 304.00 | 20 343.00 |
Buildings | 1 577.00 | 1 839.00 |
Tangible assets total | 22 881.00 | 22 182.00 |
Holdings in group member companies | 36 456.00 | 34 313.00 |
Other non-current investments | 36 456.00 | |
Investments total | 72 912.00 | 34 313.00 |
Non-current loans receivable | -36 018.00 | |
Long term receivables total | -36 018.00 | |
Finished products/goods | 37 799.00 | 45 540.00 |
Inventories total | 37 799.00 | 45 540.00 |
Current trade debtors | 42 360.00 | 37 635.00 |
Current amounts owed by group member comp. | 330 455.00 | 275 914.00 |
Prepayments and accrued income | 58 153.00 | 9 242.00 |
Current other receivables | 2 945.00 | 4 931.00 |
Current deferred tax assets | 12 193.00 | 19 626.00 |
Short term receivables total | 446 106.00 | 347 348.00 |
Cash and bank deposits | 11 219.00 | 19 706.00 |
Cash and cash equivalents | 11 219.00 | 19 706.00 |
Balance sheet total (assets) | 554 899.00 | 470 384.00 |
Equity and liabilities (kDKK)
2022 | 2023 | |
---|---|---|
Share capital | 2 100.00 | 2 100.00 |
Shares repurchased | 150 000.00 | 119 000.00 |
Other reserves | 34 244.00 | 35 101.00 |
Retained earnings | 43 368.00 | 43 250.00 |
Profit of the financial year | 120 010.00 | 119 865.00 |
Shareholders equity total | 349 722.00 | 319 316.00 |
Provisions | 7 619.00 | 9 747.00 |
Non-current other liabilities | 7 619.00 | 9 747.00 |
Non-current liabilities total | 7 619.00 | 9 747.00 |
Advances received | 104 282.00 | 76 366.00 |
Current trade creditors | 55 377.00 | 27 120.00 |
Current owed to group member | 9 068.00 | 7 095.00 |
Other non-interest bearing current liabilities | 28 831.00 | 30 740.00 |
Current liabilities total | 197 558.00 | 141 321.00 |
Balance sheet total (liabilities) | 562 518.00 | 480 131.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.